feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC
AArphra
Arphra/Issuer/7733.T

7733.T

Olympus Corporation
HealthcareMedical - DevicesJPJPYCountry macro →
$1,805.00
Jun 02, 2026
AI Brief
Revenue · FY
$1.01T
Net income
$68.17B
FY 2026
EPS · diluted
$61.20
EBITDA
$214.23B

Explain this page

Arphra AI

Company profile

DB · companies + sec_company_profile + company_profiles

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Headquarters
Shinjuku Monolith, Tokyo, 163-0914
JP
Phone
81 3 3340 2111
AI description
Arphra AI
Loading cached description…

Identifiers

  • Symbol7733.T
  • Legal nameOlympus Corporation
  • CEOFrank Drewalowski
  • SectorHealthcare
  • IndustryMedical - Devices
  • CountryJP
  • CurrencyJPY
  • ExchangeJPX
  • IPO dateJan 04, 2000
  • CIK
  • ISINJP3201200007
  • CUSIP
  • LEI
  • Employees28,838

Trading

DB · key_metrics_ttm
  • Market cap$2.04T
  • P/E (TTM)
  • P/B
  • EV / EBITDA
  • Dividend yield